Cetuximab is manufactured and distributed in North America by ImClone and Bristol-Myers Squibb, while in the rest of the world distribution is by Merck KGaA.
Cetuximab is manufactured and distributed in North America by Bristol-Myers Squibb and Eli Lilly and Company. In the rest of the world distribution is by Merck KGaA.